Cite
HARVARD Citation
Lucas, M. et al. (n.d.). BDTX-1535, a fourth generation EGFR inhibitor, targeting intrinsic and acquired resistance mutations in NSCLC. European journal of cancer. pp. S22-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lucas, M. et al. (n.d.). BDTX-1535, a fourth generation EGFR inhibitor, targeting intrinsic and acquired resistance mutations in NSCLC. European journal of cancer. pp. S22-. [Online].